J Dig Cancer Rep.  2020 Jun;8(1):51-55.

Prophylaxis of Venous Thromboembolism in Patients with Pancreatic Cancer

Affiliations
  • 1Division of Gastroenterology and Hepatology, Department of Internal Medicine, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Korea

Abstract

Prognosis of patients with pancreatic cancer is poor due to difficulty in early diagnosis and low resectability rate at the time of diagnosis. Apart from the progression of cancer, venous thromboembolism― a complication that can increase patient mortality ― is known to occur frequently in pancreatic cancer. This review was aimed at identifying whether venous thromboembolism is more common in pancreatic cancer than in other cancer types. In addition, we reviewed several studies to determine whether thromboprophylaxis increases the survival rates of patients with pancreatic cancer.

Keyword

Low‐Molecular‐Weight Heparin; Oral anticoagulant; Pancreatic cancer; Thromboprophylaxis; Venous thromboembolism
Full Text Links
  • JDCR
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
    DB Error: unknown error